Business Context and Reporting Period
Company: Marchex, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 20, 2019
Reporting Period: Single event disclosure regarding insider trading plan adoption.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a regulatory disclosure regarding an executive trading plan and does not contain financial performance data.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document discloses the adoption of a Rule 10b5-1 trading plan by an executive officer.
Guidance, Outlook, and Management Commentary
Executive Action: Michael Arends, Chief Financial Officer and member of the Office of the CEO, adopted a written trading plan with Merrill Lynch to purchase shares of Marchex's Class B common stock.
Plan Details:
- Purpose: Purchase of specified share amounts at specific market prices.
- Duration: Ends on the earlier of the purchase of the specified aggregate share amount or December 8, 2020.
- Compliance: Adopted in accordance with the Marchex Code of Conduct and Rule 10b5-1, which permits trading when insiders are not in possession of material non-public information.
Investor Verification Checklist
- Verify the specific share amounts and price triggers in the Rule 10b5-1 plan via subsequent Form 4 filings.
- Confirm the plan's termination date or completion status by December 8, 2020.
- Review the Marchex Code of Conduct to ensure the plan aligns with internal governance policies.
- Monitor for any future 8-K filings if the plan is amended or terminated early.